The lack of effective treatments for Alzheimer’s have spurred scientists to rethink the dominant approach to tackling the disease: the amyloid hypothesis. This hypothesis…
Moving into a care home is often a major transition in people’s lives, but new research shows that men tend to have a harder…
The opioid crisis has long plagued the U.S. An estimated 136 Americans will die each day from overdosing on opioids, an alarming figure that…
UPDATE: 3 March 2024, 8:27 P.M. ET. In February 2024, Biogen took Aduhelm off the market, citing financial concerns. Although the drug did receive…
Glucose is one of the brain’s main sources of fuel, providing energy for our body’s cells. But the brain’s ability to metabolize glucose becomes…
With the ongoing pandemic, Vanessa Steil has been on pins and needles, hoping her 93-year-old grandmother’s care facility wouldn’t shut down visitation. Two days…
Diagnosed with early-onset Alzheimer’s at 63 years old, Doreen Monks shares her insights on paving a new path in her life. Doreen Monks never…
What if you could augment your brain — becoming smarter, more focused, and more aware — for the price of $50 a month? Or,…
A new study predicts dementia cases will rise three-fold. Developing countries are expected to be the hardest hit. Eastern sub-Saharan Africa, North Africa and…
Plagued by dementia symptoms for years, Michael Ellenbogen discusses the ongoing ambiguity surrounding his Alzheimer’s diagnosis. Michael Ellenbogen was reaching the height of his…
Here’s how VOA’s 5 founders — including reporter Phil Gutis — responded to recent Aduhelm Medicare announcement. A few months ago, I received an…
Joe Brazeal reflects on lessons learned as a father and caregiver. Joe Brazeal’s wife, Kimberly Brazeal, was only 42 years old when she began…
UPDATE: 3 March 2024, 8:25 P.M. ET. In February 2024, Biogen took Aduhelm off the market, citing financial concerns. Although the drug did receive…
Nearly two full years into the COVID-19 pandemic, researchers are still in the process of learning what’s really going on inside the heads of…
UPDATE: 3 March 2024, 8:18 P.M. ET. In February 2024, Biogen took Aduhelm off the market, citing financial concerns. Although the drug did receive…